Astellas Pharma Inc Congressional Trading
According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 13 trades in Astellas Pharma Inc (PINK: ALPMY) since 2016, across 3 members, worth an estimated $275.51K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 8 buys against 5 sells, a modestly buy-led skew, with Democratic members responsible for 23% of the trades and Republican members 77%. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Astellas Pharma Inc (ALPMY) stock overview and the complete trade table below.
Price & congressional trade timeline
Party breakdown
Astellas Pharma congressional trading activity
| Politician | Published | Traded | Filed After | Type | Size | Return | |
|---|---|---|---|---|---|---|---|
| No congressional trades in this period. | |||||||
Astellas Pharma (ALPMY) congressional trading FAQ
Can members of Congress legally trade Astellas Pharma (ALPMY) stock?
Yes. Members of Congress are permitted to trade individual stocks, including Astellas Pharma (ALPMY), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. BullishWhales tracks those disclosures; it does not imply any trade was improper.
Are congressional Astellas Pharma (ALPMY) trades public?
Yes. Every congressional trade in Astellas Pharma (ALPMY) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.
How many times has Congress traded Astellas Pharma (ALPMY)?
Members of Congress have disclosed 13 trades in Astellas Pharma (ALPMY) worth $275.51K across 3 members, according to public STOCK Act filings.
Do Democrats or Republicans trade Astellas Pharma (ALPMY) more?
Across disclosed Astellas Pharma (ALPMY) trades, 23% were by Democrats and 77% by Republicans, led by Republicans (77%).
Browse all stocks Congress tradesCongressional trading overviewAstellas Pharma (ALPMY) stock overview
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.